Sarcomatoid Carcinoma — Trials

Sarcomatoid Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

37 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 20
Recruiting: 8
Ph III recruiting: 0
Growth YoY: —
Industry share: 5%
Top sponsor: City of Hope Medical Center
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (4)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03685448	ANZUP - Non-clear Cell Post Immunotherapy CABozantinib (UNICAB)(UNICAB)	completed	Phase 2	35	Australian and New Zealand Urogenital and Prostate Cancer Trials GroupOTHER	1	Aug 8, 2025	clinicaltrials
NCT01767636	Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer	completed	Phase 2	38	Mayo ClinicOTHER	1	Mar 3, 2025	clinicaltrials